PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT)

Running, not enrolling · Not applicable

Conditions studied: Prostate Cancer

In brief

Men with prostate cancer with Gleason Score of 8 or greater or clinical/radiographic evidence of T3 disease will be considered for this trial.

Key facts

Study ID

NCT03663218

Run by

Weill Medical College of Cornell University

People needed

16

Starts

2018-10-24

Expected to finish

2027-12-31

Last updated by the study team

2026-03-18

Who can join

Age: 18 and older, up to 90. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men aged greater than equal to18 with histologically confirmed primary prostate cancer.
• KPS greater than equal to 70
• Patient with a negative staging bone scan.
• Patient can undergo an MRI.
• Patient with negative staging CT or MRI of pelvis. Suspicious evidence of nodal involvement on staging CT or MRI of pelvis is defined as greater than 1 cm on short axis. Documented negative biopsy of suspicious node required.
• Patient is medically fit to undergo prostatectomy.
• Patient has either Gleason Score greater than equal to 8 on biopsy and/or clinical/radiographic evidence of T3 disease.

You may not qualify if…

• Prior history of receiving pelvic radiotherapy.
• Patient is unwilling to undergo prostatectomy.
• Patient with active inflammatory bowel disease defined as currently receiving therapy for IBD.

Where it is running

• Weill Cornell Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.